The Resurgence of Chlamydia trachomatis

Journal of Obstetrics and Gynaecology Canada

Volumn 26, Issue 6, 2004, Pages 552-559

  Steben, Marc ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

Chlamydia infections; Chlamydia trachomatis; Communicable disease control; Contact tracing; Sexually transmitted diseases bacterial prevention and control

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFIXIME; CEFOXITIN; DOXYCYCLINE; OFLOXACIN;

ABDOMINAL PAIN; ABORTION; AGE DISTRIBUTION; ARTICLE; ASYMPTOMATIC DISEASE; BACTERIAL CLEARANCE; CANCER RISK; CELL CULTURE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; COMMUNICABLE DISEASE; CONCURRENT SEXUAL PARTNERSHIP; CONDOM USE; CONJUNCTIVITIS; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DISEASE TRANSMISSION; DRUG CHOICE; DRUG COST; DRUG INDICATION; DYSPAREUNIA; ECHOGRAPHY; ECTOPIC PREGNANCY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDIDYMITIS; FEMALE INFERTILITY; FEVER; FLUORESCENT ANTIBODY TECHNIQUE; GENITAL TRACT INFECTION; GONORRHEA; HEALTH CARE PLANNING; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INCUBATION TIME; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; INFECTION SENSITIVITY; INTERMETHOD COMPARISON; LUNG INFECTION; MALE INFERTILITY; MEDICAL HISTORY; MENSTRUATION DISORDER; MULTIDRUG RESISTANCE; NEOPLASM; NUCLEIC ACID AMPLIFICATION; OTITIS MEDIA; PARTNER NOTIFICATION; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT SELECTION; PELVIC INFLAMMATORY DISEASE; PELVIC PAIN; PERIHEPATITIS; PNEUMONIA; POLYMERASE CHAIN REACTION; PREGNANCY; PREVALENCE; PUBLIC HEALTH; PUBLIC HEALTH NOTIFICATION; RESOURCE ALLOCATION; RISK FACTOR; SCREENING; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SEXUAL ABSTINENCE; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SINGLE DRUG DOSE; SUPERINFECTION; TRACHOMA; URETHRAL DISCHARGE; URINALYSIS; UTERINE CERVICITIS; UTERINE CERVIX CARCINOMA; UTERINE TUBE PREGNANCY; VAGINA BLEEDING; VAGINA DISCHARGE; WART VIRUS; CANADA; FEMALE; INFECTION CONTROL; MALE; PATHOGENICITY; REVIEW;

CANADA; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DISEASE NOTIFICATION; FEMALE; HUMANS; MALE; PUBLIC HEALTH; SEXUALLY TRANSMITTED DISEASES, BACTERIAL;

EID: 5644225504     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)30372-3     Document Type: Article

References (37)

1. Health Canada. STD treatment guidelines 1998 edition. Available at http://www.hc-sc.gc.ca/pphb-dgspsp/publicat/std-mts98/index.html. Accessed May 16, 2004.
2. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections 2002. MMWR Recomm Rep 2002, 51(RR-15):1-38. CDC.
3. Patrick DM. Chlamydia control: components of an effective control strategy to reduce the incidence of Chlamydia trachomatis. Can J Hum Sex 1997:6(2). Available at . Accessed May 16, 2004.
4. Martin DH, Mroczkowski TF, Dalu ZA, McCarty J, Jones RB, Hopkins SJ A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group. N Engl J Med 1992, 327(13):921-925.
5. Lambert G, Steben M Bacterial STIs make a comeback. Prévention en pratique médicate 2002.
6. Xia M, Bumgarner RE, Lampe MF, Stamm WE. Chlamydia trachomatis infection alters host cell transcription in diverse cellular pathways. J Infect Dis 2003, 187:424-434.
7. Health Canada, Population and Public Health Branch. Genital Chlamydia. Available at . Accessed May 16, 2004.
8. Simms I Epidemiology. International handbook of Chlamydia 2001, 4. Euromed Communications Ltd, Haslemere (Surrey).
9. Navarro C, Jolly A, Nair R, Chen Y Risk factors for genital Chlamydial infection. J Sex Reprod Med 2003, 3(1):23-34.
10. Sexually transmitted disease surveillance 2001, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2001, Atlanta (GA).
11. Reported genital Chlamydia cases and rates in Canada by age group and sex 1991, Health Canada, Population and Public Health Branch.
12. Reported cases and rates of notifiable STI from January I to June 30, 2003 and January I to June 30, 2002 2003, Health Canada, Population and Public Health Branch.
13. Health Canada, Division of STD Prevention and Control, Bureau of HIV/AIDS, STD and TB, Laboratory Centre for Disease Control. Proceedings of the STD Research Forum and National Goals Strategy Meeting; February 25-26, 1999; Ottawa, Ontario. Available at . Accessed May 16, 2004.
14. Direction de santé publique de Montréal. Infection génitale à Chlamydia trachomatis (fin de la période 04-2004). Available at . Accessed May 16, 2004.
15. Internet use and early syphilis infection among men who have sex with men - San Francisco, California, 1999-2003 MMWR Morb Mortal Wkly Rep. 2003 Dec 19;52(50): 1229-32.
16. Bellis MA, Hughes K, Thomson R, Bennett A. Sexual behaviour of young people in international tourist resorts. SexTransm Infect 2004, 80(1):43-47.
17. Henricksen K. Harm reduction in the rave community. Focus 2000, 15(4):1-4.
18. Jones RB, Rabinovitch RA, Katz B, Batteiger BE, Quinn RS, Terho P Chlamydia trachomatis in the pharynx and rectum of heterosexual patients at risk for genital infection. Ann Intern Med 1985, 102:757-762.
19. Stamm WE Chlamydia trachomatis infections of the adults. Sexually transmitted diseases 1999, 407-409. McGraw-Hill, New York. 3rd. K.K. Holmes, F. Sparling, P.A. Mardh, S.M. Lemon, W.E. Stamm, P. Piot (Eds.).
20. Peipert JF. Genital chlamydial infections. N Engl J Med 2003, 349(25):2424-2430.
21. Peeling RW, Louie TL, Steben M, Louie R, Dillon E, Champoux-Hamel C Effectiveness of a point-of-care test for the diagnosis of Chlamydia trachomatis in women presenting for voluntary termination of pregnancy 2003, Poster 0706, International Society for STD Research, Ottawajuly, Accessed May 16, 2004. http://www.med.uottawa.ca/isstdr/2003_ISSTDR/media/2003_ISSTDR_Abstracts.pdf.
22. Health Canada. Highlights - 1998 edition of the Canadian STD guide-lines. Available at . Accessed May 16, 2004.
23. Berman S Resurgence of syphilis in the United States. Poster 0314, International Society for STD Research, Ottawajuly 2003, Available at . Accessed May 16, 2004.
24. Rees E Treatment of pelvic inflammatory disease. Am J Obstet Gynecol 1980, 138:1042-1047.
25. Stamm WE, Guinan ME, Johnson C, Starcher T, Holmes KK, McCormack WM. Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamydia Trachomatis. N Engl J Med 1984, 310:545-549.
26. Monif GRG "Pelvic inflammatory disease" redefined. Infect Med 2001, 18(4):190-193.
27. Hammerschlag MR Chlamydia Trachomatis infections in infants and children. Sexually transmitted diseases 1999, 1155. McGraw-Hill, New York. 3rd. K.K. Holmes, F. Sparling, P.A. Mardh, S.M. Lemon, W.E. Stamm, P. Piot (Eds.).
28. Hicks D Complications of Chlamydia Trachomatis infection in men. In: International handbook of Chlamydia 2001, 71. Euromed Communications Ltd, Haslemere (Surrey).
29. Sellors J, Howard M, Pickard L, Jang D, Mahony J, Chernesky M. Chlamydial cervicitis: testing the practice guidelines for presumptive diagnosis. CMAJ 1998, 158:41-46.
30. Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002;51 (RR-6):1-78.
31. Schachter J. Biology of Chlamydia trachomatis. In: Holmes KK, Sparling F, Mardh PA, Lemon SM, Stamm WE, Piot P, et al., editors. Sexually transmitted diseases. New York McGraw-Hill; 1999. p. 391-405.
32. Westrom L, Joesoef R, Reynolds G, Hagdu A, Thompson SE Pelvic inflammatory disease and fertility: a cohort study of 1, 844 women with laparoscopically verified disease and 657 control women with normal laparoscopy results. Sex Transm Dis 1992, 19:185-192.
33. Morré SA, van den Brule AJC, Rozendaal L, Boeke AJR, Voorhorst FJ, de Blok S The natural course of asymptomatic Chlamydia trachomatis infection: 45% clearance and no development of clinical PID after one-year follow-up. Int J STD AIDS 2002, 13(Suppl 2):12-18.
34. Comité consultatif MTS. Recommandations de dépistage des MTS. MSSS;2000.
35. Screening for Chlamydial infection: recommendations and rationale. Am J Prev Med 2001, 20(3 Suppl):90-94. U.S. Preventive Services Task Force.
36. Adair CD, Gubter M, Stoval TG, McKelroy G, Veille JC, Ernest JM Chlamydia in pregnancy: a randomized trial of azithromycin and erithromycin. Obstet Gynecol 1998, 91:165-168.
37. Wehbeh HA, Ruggeirio RM, Shahem S, Lopez G, Ali Y. Single-dose azithromycin for Chlamydia in pregnant women. J Reprod Med 1998, 43:509-514.